Blue (415 nm) and red (630–660 nm) LEDs are commonly used for acne treatment at home due to their safety, affordability, and effectiveness. Blue light targets Cutibacterium acnes by activating porphyrins, while red light reduces inflammation. Frequent sessions over weeks or months are needed, usually yielding modest results, so this method suits mild inflammatory acne or maintenance therapy.
Class IV laser devices, such as the Fotona Dynamis featuring Nd:YAG (1064 nm) and Er:YAG (2940 nm) lasers, demonstrate higher efficacy in acne management. The Nd:YAG laser effectively reduces inflammation and suppresses sebaceous gland function, addressing two key pathogenic factors of acne vulgaris.
This is achieved through the Nd:YAG FRAC3 protocol, which employs extremely brief, high peak energy pulses. This non-ablative technique preserves the superficial epidermis while creating microthermal zones and focal heating within deeper dermal layers, elevating sebaceous gland temperature to 45–50°C. This thermal effect induces protein modifications that decrease sebocyte lipid synthesis and promote a controlled wound healing cascade, characterized by downregulation of pro-inflammatory cytokines (interleukin-1β, tumor necrosis factor-α, and interleukin-8) and upregulation of anti-inflammatory mediators such as TGF-beta and interleukin-10.
Additionally, the Nd:YAG laser targets cutaneous melanin and hemoglobin. Since the sebaceous gland relies on a vascular supply for nutrient delivery, Nd:YAG irradiation can impair vascular integrity and nutrient transport, thus reducing glandular activity. A further benefit includes the enhancement of inflammation resolution via stimulation of microinjury repair mechanisms.
The Er:YAG laser is particularly effective for the treatment of acne scarring. Compared to CO2 lasers, erbium lasers offer a superior safety profile for individuals with darker skin tones and facilitate improvements in skin texture in addition to scar remodeling.





























